Greenwoods Asset Management (HK)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-29,722
Closed -$4.24M 43
2024
Q2
$4.24M Hold
29,722
0.11% 31
2024
Q1
$3.82M Buy
+29,722
New +$3.54M 0.12% 30

Other funds holding NVO

Greenwoods Asset Management (HK)'s NVO Position: Q3 2024 in Review

Greenwoods Asset Management (HK) sold out of Novo Nordisk (NVO) in Q3 2024, closing a stake of 29,722 shares — an estimated $4.24M sold.

Greenwoods Asset Management (HK) first reported a position in NVO in Q1 2024 and held it in 2 quarters. The position peaked at $4.24M in Q2 2024. 1,785 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • Greenwoods Asset Management (HK) reported no remaining Novo Nordisk position as of Q3 2024 after selling out during the quarter.
  • Greenwoods Asset Management (HK) sold 29,722 Novo Nordisk shares in Q3 2024, an estimated $4.24M.
  • Greenwoods Asset Management (HK) first reported a position in Novo Nordisk in Q1 2024 and held it in 2 quarters.
  • Greenwoods Asset Management (HK)'s Novo Nordisk position peaked at $4.24M in Q2 2024.
  • 1,785 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on Greenwoods Asset Management (HK)'s 13F filing for Q3 2024, filed 8 Nov 2024.